LOINC
Version 2.69

94327-4PhenX - human papillomavirus vaccine use protocol 100802Active

Term Description

The interviewer asks the individual whether s/he ever received a human papillomavirus (HPV) vaccination. If the response is yes, the interviewer asks about number of shots received.

If the participant answers "yes" to question 1, the interviewer should complete the rest of the protocol. If the participant answers "no," then the protocol is deemed complete.

The PhenX Working Group notes that GARDASIL® is also known internationally as Silgard.

European Medicines Agency. (2009, September 25). Silgard European Public Assessment Report.
Waknine, Y. (2006, October 2). International approvals: Singulair and Gardasil/Silgard. Medscape Today.

Note: GARDASIL® by Merck & Co. is approved by the U.S. Food and Drug Administration (FDA) for use in females ages 9-26 and males ages 9-26.

Note: CERVARIX® is manufactured by GlaxoSmithKline Biologicals and approved by the FDA for use in females ages 10-25.
Source: Regenstrief LOINC

Panel Hierarchy
Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
94327-4 PhenX - human papillomavirus vaccine use protocol 100802
Indent64663-8 Have you EVER had an HPV vaccination?
Indent64665-3 How many HPV shots did you receive? {#}

Fully-Specified Name

Component
PhenX - human papillomavirus vaccine use protocol 100802
Property
-
Time
Pt
System
^Patient
Scale
-
Method
PhenX

Additional Names

Short Name
PhenX - HPV vaccine use protocol

Basic Attributes

Class
PANEL.PHENX
Type
Clinical
First Released
Version 2.68
Last Updated
Version 2.68
Order vs. Observation
Order
Panel Type
Panel

Language Variants Get Info

zh-CNChinese (China)
PhenX - 人乳头瘤病毒疫苗使用方案 100802:-:时间点:^患者:-:PhenX
it-ITItalian (Italy)
PhenX - papillomavirus umano uso del vaccino, protocollo:-:Pt:^Paziente:-:PhenX

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94327-4